Patient perspectives and experiences with basal insulin titration in type 2 diabetes in the United States: A cross-sectional survey

Diabetes Obes Metab. 2023 May;25(5):1408-1412. doi: 10.1111/dom.14973. Epub 2023 Jan 31.

Authors

Stewart B Harris¹, Kamel Mohammedi², Monica Bertolini³, John White⁴, Valery Walker⁴, Fang Liz Zhou³, John E Anderson⁵, Jochen Seufert⁶

Affiliations

¹ Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada.
² INSERM BMC U1034, Université de Bordeaux, Pessac, France.
³ Sanofi, Bridgewater, New Jersey, USA.
⁴ Optum, Eden Prairie, Minnesota, USA.
⁵ The Frist Clinic, Nashville, Tennessee, USA.
⁶ Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

PMID: 36633521
DOI: 10.1111/dom.14973

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Blood Glucose
Cross-Sectional Studies
Diabetes Mellitus, Type 2* / drug therapy
Diabetes Mellitus, Type 2* / epidemiology
Humans
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
United States / epidemiology

Substances

Hypoglycemic Agents
Insulin
Blood Glucose